|
1
|
Liapis CD, Bell PR, Mikhailidis D,
Sivenius J, Nicolaides A, Fernandes e Fernandes J, Biasi G and
Norgren L: ESVS Guidelines Collaborators: ESVS guidelines. Invasive
treatment for carotid stenosis: Indications, techniques. Eur J Vasc
Endovasc Surg. 37(4 Suppl): S1–S19. 2009. View Article : Google Scholar
|
|
2
|
Du J, Wasserman BA, Tong W, Chen S, Lai S,
Malhotra S and Lai H: Cholesterol is associated with the presence
of a lipid core in carotid plaque of asymptomatic,
young-to-middle-aged African Americans with and without HIV
infection and cocaine use residing in inner-city Baltimore, Md.,
USA. Cerebrovasc Dis. 33:295–301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Almekkaway MK, Shehata IA and Ebbini ES:
Anatomical-based model for simulation of HIFU-induced lesions in
atherosclerotic plaques. Int J Hyperthermia. 31:433–442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libby P: Managing the risk of
atherosclerosis: The role of high-density lipoprotein. Am J
Cardiol. 88:3N–8N. 2001.
|
|
5
|
Hollingworth W, Nathens AB, Kanne JP,
Crandall ML, Crummy TA, Hallam DK, Wang MC and Jarvik JG: The
diagnostic accuracy of computed tomography angiography for
traumatic or atherosclerotic lesions of the carotid and vertebral
arteries: A systematic review. Eur J Radiol. 48:88–102. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong KS, Li H, Chan YL, Ahuja A, Lam WW,
Wong A and Kay R: Use of transcranial doppler ultrasound to predict
outcome in patients with intracranial large-artery occlusive
disease. Stroke. 31:2641–2647. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong C, Yoon W and Goldschmidt-Clermont
PJ: DNA methylation and atherosclerosis. J Nutr. 132(8 Suppl):
2406S–2409S. 2002.PubMed/NCBI
|
|
8
|
Grützmann R, Molnar B, Pilarsky C,
Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F,
Roblick UJ, et al: Sensitive detection of colorectal cancer in
peripheral blood by septin 9 DNA methylation assay. PloS One.
11:e37592008. View Article : Google Scholar
|
|
9
|
Majid MM, Mughal MK, DeMarco JK, Majid A,
Shamoun F and Abela GS: Symptomatic and asymptomatic carotid artery
plaque. Expert Rev Cardiovasc Ther. 9:1315–1330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mendelsohn AR and Larrick JW: The DNA
methylome as a biomarker for epigenetic instability and human
aging. Rejuvenation Res. 16:74–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guay SP, Brisson D, Lamarche B, Marceau P,
Vohl MC, Gaudet D and Bouchard L: DNA methylation variations at
CETP and LPL gene promoter loci: New molecular biomarkers
associated with blood lipid profile variability. Atherosclerosis.
228:413–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Zhao M, Sawalha AH, Richardson B
and Lu Q: Impaired DNA methylation and its mechanism s in CD4(+)T
cells of systemic lupus erythematosus. J Autoimmun. 41:92–99. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Robertson KD and Jones PA: DNA
methylation: Past, present and future directions. Carcinogenesis.
21:461–467. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Forsberg CW, Goldberg J, Smith NL
and Vaccarino V: MAOA promoter methylation and susceptibility to
carotid atherosclerosis: Role of familial factors in a monozygotic
twin sample. BMC Med Genet. 13:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lasseigne BN, Burwell TC, Patil MA, Absher
DM, Brooks JD and Myers RM: DNA methylation profiling reveals novel
diagnostic biomarkers in renal cell carcinoma. BMC Med. 12:2352014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu X, Ling W and Mi M: Relationship of
impairment induced by intracellular S-adenosylhomocysteine
accumulation with DNA methylation in human umbilical vein
endothelial cells treated with 3-deazaadenosine. Int J Exp Pathol.
90:638–648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong C, Yoon W and Goldschmidt-Clermont
PJ: DNA methylation and atherosclerosis. J Nutr. 132(8 Suppl):
2406S–2409S. 2002.PubMed/NCBI
|
|
18
|
Van De Voorde V, Speeckaert R, Van Gestel
D, Bracke M, De Neve W, Delanghe J and Speeckaert M: DNA
methylation-based biomarkers in serum of patients with breast
cancer. Mutat Res. 751:304–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ridker PM, Stampfer MJ and Rifai N: Novel
risk factors for systemic atherosclerosis: A comparison of
C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and
standard cholesterol screening as predictors of peripheral arterial
disease. JAMA. 285:2481–2485. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Attie AD, Kastelein JP and Hayden MR:
Pivotal role of ABCA1 in reverse cholesterol transport influencing
HDL levels and susceptibility to atherosclerosis. J Lipid Res.
42:1717–1726. 2001.PubMed/NCBI
|
|
21
|
Nissen SE, Tuzcu EM, Brewer HB, Sipahi I,
Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD,
et al: Effect of ACAT inhibition on the progression of coronary
atherosclerosis. N Engl J Med. 354:1253–1263. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shan W, Palkar PS, Murray IA, McDevitt E,
Kennett MJ, Kang BH, Isom HC, Perdew GH, Gonzalez FJ and Peters JM:
Ligand activation of peroxisome proliferator-activated receptor
beta/delta (PPARbeta/delta) attenuates carbon tetrachloride
hepatotoxicity by downregulating proinflammatory gene expression.
Toxicol Sci. 105:418–428. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khovidhunkit W, Kim MS, Memon RA,
Shigenaga JK, Moser AH, Feingold KR and Grunfeld C: Effects of
infection and inflammation on lipid and lipoprotein metabolism
mechanisms and consequences to the host. J Lipid Res. 45:1169–1196.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang Y, Yang X, Ma L, Cai X, Wang L, Yang
C, Li G, Zhang M, Sun W and Jiang Y: Homocysteine-mediated
cholesterol efflux via ABCA1 and ACAT1 DNA methylationin THP-1
monocyte-derived foam cells. Acta Biochim Biophys Sin (Shanghai).
45:220–228. 2013. View Article : Google Scholar
|
|
25
|
Ma S, Zhang H, Sun W, Gong H, Wang Y, Ma
C, Wang J, Cao C, Yang X, Tian J, et al: Hyperhomocysteinemia
induces cardiac injury by up-regulation of p53-dependent Noxa and
Bax expression through the p53 DNA methylation in ApoE (−/−) mice.
Acta Biochim Biophys Sin (Shanghai). 45:391–400. 2013. View Article : Google Scholar
|
|
26
|
Frangogiannis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar
|
|
27
|
Glöckner SC, Dhir M, Yi JM, McGarvey KE,
Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits
KM, et al: Methylation of TFPI2 in stool DNA: A potential novel
biomarker for the detection of colorectal cancer. Cancer Res.
69:4691–4693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Melotte V, Lentjes MH, van den Bosch SM,
Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL,
Partouns-Hendriks IE, Stessels F, Louwagie J, et al: N-Myc
downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor
gene and potential biomarker for colorectal cancer. J Natl Cancer
Inst. 101:916–927. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoseini SM, Kalantari A, Afarideh M,
Noshad S, Behdadnia A, Nakhjavani M and Esteghamati A: Evaluation
of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate
cardiometabolic risk marker in metabolic syndrome: Results from
double-blinded nested case-control study. Metabolism. 64:527–538.
2015. View Article : Google Scholar : PubMed/NCBI
|
